Abstract
Gene therapy has emerged as a transformative approach in modern medicine, offering new avenues for the treatment of previously incurable genetic disorders. The integration of gene therapy into drug development presents an opportunity to correct underlying genetic defects and to enhance the specificity and efficacy of therapeutic interventions. This article explores the future of gene therapy, highlighting recent advancements, challenges, and the potential for its integration into broader drug development strategies. Furthermore, it discusses the regulatory, ethical, and clinical considerations that will shape the evolution of gene therapy in drug development, and how it may revolutionize personalized medicine.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.